Some researchers suggested the concentrations of serum Ghrelin were associated with the risk of gastric non-cardia adenocarcinoma (GNCA) and esophagogastric junctional adenocarcinoma (EGJA) 34. The gene discussed is GHRL; the disease is gastroesophageal junction adenocarcinoma.